VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 124 filers reported holding VBI VACCINES INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $25,000 | -56.9% | 64,737 | -22.9% | 0.00% | – |
| Q3 2022 | $58,000 | -10.8% | 83,937 | +0.0% | 0.00% | – |
| Q2 2022 | $65,000 | -53.2% | 83,935 | 0.0% | 0.00% | – |
| Q1 2022 | $139,000 | -29.1% | 83,935 | -0.9% | 0.00% | – |
| Q4 2021 | $196,000 | +37.1% | 84,705 | +83.4% | 0.00% | – |
| Q3 2021 | $143,000 | -8.3% | 46,190 | +0.4% | 0.00% | – |
| Q2 2021 | $156,000 | +22.8% | 45,985 | +11.7% | 0.00% | – |
| Q1 2021 | $127,000 | +6.7% | 41,163 | -1.7% | 0.00% | -100.0% |
| Q3 2020 | $119,000 | -27.4% | 41,890 | -20.2% | 0.00% | 0.0% |
| Q2 2020 | $164,000 | +1390.9% | 52,520 | +355.1% | 0.00% | – |
| Q1 2020 | $11,000 | -35.3% | 11,540 | -9.8% | 0.00% | – |
| Q4 2019 | $17,000 | +240.0% | 12,800 | +13.3% | 0.00% | – |
| Q3 2019 | $5,000 | – | 11,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 55,042,465 | $171,182,000 | 2.49% |
| GENERAL AMERICAN INVESTORS CO INC | 1,877,497 | $5,839,000 | 0.50% |
| HighVista Strategies LLC | 41,271 | $129,000 | 0.08% |
| ArchPoint Investors | 65,000 | $202,000 | 0.06% |
| FIRST MIDWEST BANK TRUST DIVISION | 136,714 | $425,000 | 0.06% |
| FNY Investment Advisers, LLC | 24,683 | $76,000 | 0.04% |
| GRIMES & COMPANY, INC. | 257,960 | $802,000 | 0.04% |
| Cambridge Investment Research Advisors, Inc. | 2,065,953 | $6,425,000 | 0.03% |
| Ergoteles LLC | 171,127 | $532,000 | 0.02% |
| J.W. COLE ADVISORS, INC. | 71,100 | $221,000 | 0.02% |